BRÈVE

sur Eckert & Ziegler Strahlen- Und Medizintechnik AG (isin : DE0005659700)

Eckert & Ziegler Increases Sales and Earnings, Raises Profit Forecast for 2024

Graphique de l'évolution du cours de l'action Eckert & Ziegler Strahlen- Und Medizintechnik AG (EBR:EUZ).

Eckert & Ziegler SE has reported significant growth in its financial performance for the second quarter and first half of 2024. Sales in the second quarter reached EUR 77.8 million, up from EUR 60.1 million in the previous year. EBIT before special items grew to EUR 17.5 million, compared to EUR 12.0 million last year. Net income also saw a rise, reaching EUR 9.5 million, up from EUR 6.2 million.

For the first half of 2024, the company achieved sales of EUR 145.4 million, a marked increase from EUR 118.0 million in the previous year. EBIT before special items amounted to EUR 32.5 million, up from EUR 22.6 million. Net income for this period was EUR 18.0 million, compared to EUR 10.9 million in the prior year.

The Executive Board has raised its profit forecast for 2024. The forecast for EBIT before special items is now approximately EUR 55 million. The sales forecast remains unchanged at just under EUR 265 million. The company will publish its full figures for the first half of 2024 on August 9, 2024.

R. E.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Eckert & Ziegler Strahlen- Und Medizintechnik AG